Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
- PMID: 7707810
- DOI: 10.1016/s0140-6736(95)90008-x
Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
Abstract
Several studies have shown a relation between hyperhomocysteinaemia and arterial vascular disease. We looked at the association between hyperhomocysteinaemia and venous thrombosis which could be clinically important as hyperhomocysteinaemia is easily corrected by vitamin supplementation. We studied 185 patients with a history of recurrent venous thrombosis and 220 controls from the general population. Homocysteine concentrations were measured before and 6 h after oral methionine loading. We defined hyperhomocysteinaemia as the homocysteine concentration above the fasting or the postmethionine value found for the 90th percentile of the controls. Of the 185 patients with recurrent thrombosis, 46 (25%) had fasting homocysteine concentrations above the 90th percentile or the controls (odds ratio is 3.1 [1.8-5.5]). After adjustment for age, sex, and menopausal status the odds ratio was 2.0 (1.5-2.7). Similar results were found for the post-methionine value (unadjusted odds ratio 3.1 [1.7-5.5], adjusted 2.6 [1.9-3.5]). Hyperhomocysteinaemia is a common risk factor for recurrent venous thrombosis and can lead to a two-fold or three-fold increase in risk.
Comment in
-
Is homocysteinaemia a risk factor for venous thrombosis and atherosclerotic vascular disease?Lancet. 1995 Jul 8;346(8967):127. Lancet. 1995. PMID: 7603202 No abstract available.
Similar articles
-
Hyperhomocysteinaemia and the risk of recurrent venous thrombosis: results from the MEGA follow-up study.Br J Haematol. 2019 Oct;187(2):219-226. doi: 10.1111/bjh.16075. Epub 2019 Jul 1. Br J Haematol. 2019. PMID: 31257573 Clinical Trial.
-
Hyperhomocysteinaemia in Behçet's disease.Rheumatology (Oxford). 2001 Jun;40(6):687-90. doi: 10.1093/rheumatology/40.6.687. Rheumatology (Oxford). 2001. PMID: 11426028
-
Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens.Vasc Med. 2002 Feb;7(1):29-33. doi: 10.1191/1358863x02vm407ra. Vasc Med. 2002. PMID: 12083731 Review.
-
Low fasting methionine concentration as a novel risk factor for recurrent venous thrombosis.Thromb Haemost. 2006 Oct;96(4):492-7. Thromb Haemost. 2006. PMID: 17003928
-
Hyperhomocysteinaemia and vascular disease.Blood Rev. 1998 Mar;12(1):23-34. doi: 10.1016/s0268-960x(98)90027-3. Blood Rev. 1998. PMID: 9597195 Review.
Cited by
-
Homocysteine Is Associated With Future Venous Thromboembolism in 2 Prospective Cohorts of Women.Arterioscler Thromb Vasc Biol. 2021 Jul;41(7):2215-2224. doi: 10.1161/ATVBAHA.121.316397. Epub 2021 May 27. Arterioscler Thromb Vasc Biol. 2021. PMID: 34039021 Free PMC article.
-
Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.Am J Hum Genet. 1996 Jan;58(1):35-41. Am J Hum Genet. 1996. PMID: 8554066 Free PMC article.
-
Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis.Mol Diagn. 2000 Mar;5(1):59-66. doi: 10.1007/BF03262024. Mol Diagn. 2000. PMID: 10837091
-
Hyperhomocysteinaemia and associated disease.Pharm World Sci. 1997 Jun;19(3):126-32. doi: 10.1023/a:1008634632501. Pharm World Sci. 1997. PMID: 9259028 Review.
-
A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?Am J Hum Genet. 1998 May;62(5):1044-51. doi: 10.1086/301825. Am J Hum Genet. 1998. PMID: 9545395 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources